510(k) device
Dimension Vista Ctni Flex Reagent Cartridge
Dade Behring, Inc. · Immunoassay Method, Troponin Subunit (MMI, Class II) · First FDA decision Apr 14, 2006, newest Mar 19, 2007Heart attack (myocardial infarction)Heart attack and heart failure blood tests
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Dimension Vista Ctni"
MAUDE reports
0
Brand "Dimension Vista Ctni", since 2015
PubMed studies
5
Mentioning "Dimension Vista Ctni"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dimension Vista Ctni Flex Reagent Cartridge
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K063756 · Decided Mar 19, 2007 · 90 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Dimension Vista Ctni", any status and sponsor, newest update first.
No registered device study names "Dimension Vista Ctni".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Dimension Vista Ctni", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MMI
7,546 reports: 7,009 malfunction, 528 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-1671-2018 · Started Jan 2, 2018 · Posted by FDA May 4, 2018
Reason given: Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA,...
Cause as FDA categorized it: Error in labeling · Device type: Immunoassay Method, Troponin Subunit (MMI)
Published research
The most relevant PubMed records for "Dimension Vista Ctni"[tiab]. The summary above synthesizes these.
- Impact of physical activity of individuals and creatine kinase on 99th percentiles of troponin I assays.
Petersmann A, Ittermann T, Frieß C, et al. · Clin Chim Acta · 2016
- Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay.
Lippi G, Ferrari A, Gandini G, et al. · Clin Chem Lab Med · 2017
- Comparison of the 99th percentiles of three troponin I assays in a large reference population.
Petersmann A, Ittermann T, Fries C, et al. · Clin Chem Lab Med · 2013Comparative Study
- Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.
Kelley WE, Lockwood CM, Cervelli DR, et al. · Clin Biochem · 2009
- Clinical performance of cardiac Troponin I: A comparison between the POCT AQT90 FLEX and the Dimension Vista analyzer in an emergency setting.
Mion MM, Bragato G, Casarotti A, et al. · Clin Biochem · 2017Comparative Study, Evaluation Study
Other devices of this type
Also filed under product code MMI.
- Access hsTnIBeckman Coulter, Inc. · 510(k) 2025
- Elecsys Troponin T Gen 5Roche Diagnostics · 510(k) 2021
- i-STAT hs-TnI cartridge with the i-STAT Alinity SystemAbbott Point of Care, Inc. · 510(k) 2026
- VITROS Immunodiagnostic Products hs Troponin I Reagent PackOrtho-Clinical Diagnostics, Inc. · 510(k) 2025
- Atellica® IM High-Sensitivity Troponin I (TnIH)Siemens Healthcare Diagnostics, Inc. · 510(k) 2024
- Alinity i STAT High Sensitivity Troponin-IAbbott Laboratories Diagnostics Division · 510(k) 2023
- Vidas Troponin I Ultra (Tniu) Assay, Model 30 448bioMerieux, Inc. · 510(k) 2007
- Abbott Axsym Troponin-I AdvAbbott Laboratories · 510(k) 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.